Class 4 Medicines Defect Information: Prednisolone 5mg Tablets (MDR 61-04/19)
Genesis Pharmaceuticals Ltd has informed us that there is an error on the Braille for the above batches which means that the strength reads as 1mg instead of 5mg. The printed text is correct on all packaging.
Company name
Genethics Europe Ltd (Distributed by Genesis Pharmaceuticals Ltd )
Product description
Prednisolone 5mg Tablets. PL 42976/0037.
| Batch Number | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 1809653 | 08/2021 | 1 x 28 | 28/01/2019 |
| 1809654 | 08/2021 | 1 x 28 | 28/01/2019 |
| 1809655 | 08/2021 | 1 x 28 | 30/01/2019 |
| 1809656 | 08/2021 | 1 x 28 | 06/02/2019 |
| 1809657 | 08/2021 | 1 x 28 | 26/02/2019 |
Advice for healthcare professionals
There is a risk to patients who have compromised eye-sight and who rely solely on Braille to determine their tablet strength.
Packs from the above distributor with the above batch numbers should not be dispensed to patients who rely solely on Braille.
We understand that alternative batches of the product are available from a number of suppliers.
Further information
For further information, please contact Genesis Pharmaceuticals Ltd, on 020 7201 0400.
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.
Download the document